Eyes and vision
7 results
Applied filters
Preparing to use ranibizumab biosimilar
5 November 2025Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
The licence and supporting evidence for ranibizumab biosimilars
5 November 2025Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
The licence and supporting evidence for aflibercept biosimilars
26 September 2025Aflibercept 2mg biosimilars Afqlir, Eydenzelt, Yesafili and Vgenfli are expected in December 2025 for NHS use. Learn about supporting evidence and differences.
Preparing to use aflibercept 2mg biosimilar
4 July 2025Aflibercept 2mg biosimilars for use in ophthalmology are expected in December 2025 for NHS use. We offer general information and implementation advice.
Supporting people with sight loss in managing their medicines
20 March 2025Guidance for pharmacy staff about how to support people with sight loss in using their medicines and accessing pharmacy services.
Using chloramphenicol during breastfeeding
16 June 2022Topical chloramphenicol can be used with caution and monitoring. Systemic chloramphenicol is not recommended. Advice applies to full term and healthy infants.
In-use shelf life of eye drops and ointments
16 December 2019In use expiry dates of eye preparations should be assigned to minimise the risk of microbial contamination and proliferation